ArticleProceedings of the National Academy of Sciences of the United States of America2018
Protective immunity in recurrent
Open access · bronzeAbstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.
0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
58 citing papers in PubMed, 75 citations in OpenAlex.
- Role and plasticity of Th1 and Th17 responses in immunity toHuman vaccines & immunotherapeutics · 2019Trial
- Epigenetic profiling reveals M1 macrophages as the primary drivers of trained immunity in HSV-1 latently infected mice.PLoS pathogens · 2026Article
- Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of HumanAntibiotics (Basel, Switzerland) · 2026Article
- Collagen binding adhesin restricts Staphylococcus aureus skin infection.Nature communications · 2026Article
- Paclitaxel induces trained immunity via the GPR183-STING axis to enhance host defense against MRSA infection.Veterinary research · 2026Article
- Will It Be Possible in the Future to Target Innate Immunity Against Staphylococcus aureus Using Resident Microbiota and Plant Extracts?Journal of immunology research · 2026Article
- Taming Superbugs: Current Progress and Challenges in Combating ESKAPE Pathogens.Pathogens (Basel, Switzerland) · 2025Review
- Activating Ferroptosis of M1 Macrophages: A Novel Mechanism of Asiaticoside Encapsuled in GelMA for Anti-Inflammation in Diabetic Wounds.Exploration (Beijing, China) · 2025Article
- Protection acquired upon intraperitoneal group aVirulence · 2025Article
- Review
- Review
- Dextran-functionalized cerium oxide nanoparticles for treating diabetic wound infections by synergy between antibacterial activity and immune modulation.Materials today. Bio · 2025Article
- Ablation of the deubiquitinating enzyme cylindromatosis (CYLD) augments STAT1-mediated M1 macrophage polarization and fostersFrontiers in immunology · 2025Article
- Article
- Immune Responses to Methicillin-ResistantVaccines · 2024Review
- Tensor modeling of MRSA bacteremia cytokine and transcriptional patterns reveals coordinated, outcome-associated immunological programs.PNAS nexus · 2024Article
- Trained immunity in recurrent Staphylococcus aureus infection promotes bacterial persistence.PLoS pathogens · 2024Article
- Immunostimulatory DNA Hydrogel Enhances Protective Efficacy of Nanotoxoids against Bacterial Infection.Advanced materials (Deerfield Beach, Fla.) · 2023Article
- Combined Inhibition of the TGF-β1/Smad Pathway byInternational journal of molecular sciences · 2023Article
- Staphylococcus aureus host interactions and adaptation.Nature reviews. Microbiology · 2023Review
Corrections and comments
- Commented on by
Authors and funding
12 authors at 3 institutions in 1 country.
Liana C ChanLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.ORCID 0000-0003-2567-4418
Maura RossettiDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles Immunogenetics Center, Los Angeles, CA 90095.
Lloyd S MillerDepartment of Dermatology, The Johns Hopkins University, Baltimore, MD 21231.
Scott G FillerLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
Colin W JohnsonLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
Hong K LeeLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
Huiyuan WangLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
David GjertsonDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles Immunogenetics Center, Los Angeles, CA 90095.
Vance G FowlerDivision of Infectious Diseases, Department of Medicine, Duke University, Durham, NC 27704.
Elaine F ReedDepartment of Pathology and Laboratory Medicine, University of California, Los Angeles Immunogenetics Center, Los Angeles, CA 90095.
Michael R YeamanLos Angeles Biomedical Research Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502; MRYeaman@ucla.edu.
MRSA Systems Immunobiology Group
University of California, Los Angeles · USDuke University · USJohns Hopkins University · US
Funding
Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1MSTAT3-mediated immunity to Staphylococcus aureus in skinR01AR069502 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ARCHER, NATHAN K. · 2016 to 2020
$1.8MMitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2MData commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598kHuman in vivo Th17 cell responses in cutaneous immunity to Staphylococcus aureusR21AI126896 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MILLER, LLOYD S · 2016 to 2017
$446kNIAID NIH HHS R21 AI126896NIAID NIH HHS R33 AI111661NIAID NIH HHS U01 AI124319NIAMS NIH HHS R01 AR069502NIH HHS S10 OD018164
Abstract
PubMed holds no abstract for this paper.
Indexed as
Adoptive TransferAnimalsChemokine CCL5Chemokine CXCL10Dendritic CellsDisease Models, AnimalHomeodomain ProteinsImmunity, InnateImmunologic MemoryInterferon-gammaInterleukin-17Interleukin-6MacrophagesMaleMethicillin-Resistant Staphylococcus aureusMiceCcl5 protein, mouseChemokine CCL5Chemokine CXCL10Cxcl10 protein, mouseHomeodomain ProteinsIFNG protein, mouseIl17a protein, mouseInterferon-gammaInterleukin-17Interleukin-6interleukin-6, mouseRAG-1 proteinadoptive transferinnate immune memorymacrophagerecurrent skin infectionStaphylococcus aureus
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.